Prediction of stone disease by discriminant analysis and artificial neural networks in genetic polymorphisms: A new method

BJU International

Volumn 91, Issue 7, 2003, Pages 661-666

  Chiang, D ^a   Chiang, H C ^a,b   Chen, W C ^c   Tsai, F J ^c  

^a CHING YUN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Artificial neural network; Discriminant analysis; Single nucleotide polymorphisms; Urolithiasis

Indexed keywords

CALCIUM OXALATE; CYTOCHROME P450C17; UROKINASE; UVOMORULIN; VASCULOTROPIN;

ACCURACY; ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CALCIUM OXALATE STONE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; DRINKING BEHAVIOR; ENVIRONMENT; EXERCISE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UROLITHIASIS;

ADULT; AGED; DISCRIMINANT ANALYSIS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; URINARY CALCULI; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038582776     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.03067.x     Document Type: Article

References (27)

1. Lee YH, Huang WC, Tsai JY et al. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 2002; 68: 172-7
2. McGeown MG. Inheritance of calcium renal stones. Lancet 1968; 20: 866
3. Resnick M, Pridgen DB, Goodman HO. Genetic predisposition to formation of calcium oxalate renal calculi. New Engl J Med 1968; 278: 1313-8
4. Goodman HO, Holmes RP, Assimos DG. Genetic factors in calcium oxalate stone disease. J Urol 1995; 153: 301-7
5. Finne P, Finne R, Stenman UH. Neural network analysis of clinicopathological factors in urological disease: a critical evaluation of available techniques. BJU Int 2001; 88: 825-31
6. Foresee FD, Hagan MT. Gauss-Newton approximation to Bayesian Regularization. Proceedings 1997 Int Joint Conf Neural Networks 1997; 3: 1930-5
7. Tewari A, Narayan P. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks. J Urol 1998; 160: 430-6
8. Snow PB, Smith DS, Catalona WJ. Artificial neural networks in the diagnosis and the prognosis of prostate cancer: a pilot study. J Urol 1994; 152: 1923-6
9. Sonke GS, Heskes T, Verbeek AL, de la Rosette JJ, Kiemeny LA. Prediction of bladder outlet obstruction in men with lower urinary tract symptoms using artificial neural networks. J Urol 2000; 163: 300-5
10. Cummings JM, Boullier JA, Izenberg SD, Kitchens DM, Kothandapani RV. Prediction of spontaneous ureteral calculous passage by an artificial neural network. J Urol 2000; 164: 326-8
11. Chen WC, Lu HF, Chen HY, Hsu CD, Tsai FJ. Arginine form of p21 gene codon 31 is less prominent in patients with calcium oxalate stone. Urol Res 2001; 29: 94-7
12. Chen WC, Wu HC, Lin WC, Wu MC, Hsu CD, Tsai FJ. The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men. BJU Int 2001; 88: 432-6
13. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996; 143: 240-7
14. Yoon Y, Swales GJR, Margavio TMA. A comparison of discriminant analysis versus artificial neural networks. J Operational Res Soc 1993; 44: 51-60
15. Zell A. Simulation Neuronaler Netze. Bonn: Addison-Wesley, 1994
16. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991; 47: 211-8
17. West AF, O'Donnell M, Charlton RG et al. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer. Br J Cancer 2001; 85: 576-83
18. Ferrer FA, Miller LJ, Andrawis RI et al. Vascular endothelial growth factor (VEGF) expression in human prostate cancer, in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol 1997; 157: 2329-33
19. Joseph IB, Nelson JB, Denmeade SR, Isaacs JT. Androgen regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res 1997; 3: 2507-11
20. Cvetkovic D, Movsas B, Dicker AP et al. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology 2001; 57: 821-5
21. Finlayson B, Reid F. The expectation of free and fixed particles in urinary stone disease. Invest Urol 1978; 15: 442-8
22. Hackett RL, Shevock PN, Khan SR. Cell injury associated calcium oxalate crystalluria. J Urol 1990; 144: 1535-8
23. Kok DJ, Khan SR. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 1994; 46: 847-54
24. Scheid C, Koul H, Hill WA et al. Oxalate toxicity in LLC-Pk1 cells. Role of free radicals. Kidney Int 1996; 49: 413-9
25. Thamilselvan S, Byer KJ, Hackett RL, Khan SR. Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 2000; 164: 224-9
26. deWater R, Noordermeer C, Houtsmuller AB et al. Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kid Dis 2000; 36: 615-25
27. Pratt RE, Dzau VJ. Genomics and hypertension Concepts, potentials, and opportunities. Hypertension 1999; 33: 238-47